Caughey Gillian E, Kalisch Ellett Lisa M, Wong Te Ying
Quality Use of Medicines and Pharmacy Research Centre, Sansom Institute, School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, Australia.
BMJ Open. 2014 Apr 28;4(4):e004625. doi: 10.1136/bmjopen-2013-004625.
Indicators of potentially preventable hospitalisations have been adopted internationally as a measure of health system performance; however, few assess appropriate processes of care around medication use, that if followed may prevent hospitalisation. The aim of this study was to develop and validate evidence-based medication-related indicators of potentially preventable hospitalisations.
Australian primary healthcare.
Medical specialists, general practitioners and pharmacists. A modified RAND appropriateness method was used for the development of medication-related indicators of potentially preventable hospitalisations, which included a literature review, assessment of the strength of the supporting evidence base, an initial face and content validity by an expert panel, followed by an independent assessment of indicators by an expert clinical panel across various disciplines, using an online survey.
Analysis of ratings was performed on the four key elements of preventability; the medication-related problem must be recognisable, the adverse outcomes foreseeable and the causes and outcomes identifiable and controllable.
A total of 48 potential indicators across all major disease groupings were developed based on level III evidence or greater, that were independently assessed by 78 expert clinicians (22.1% response rate). The expert panel considered 29 of these (60.4%) sufficiently valid. Of these, 21 (72.4%) were based on level I evidence.
This study provides a set of face and content validated indicators of medication-related potentially preventable hospitalisations, linking suboptimal processes of care and medication use with subsequent hospitalisation. Further analysis is required to establish operational validity in a population-based sample, using an administrative health database. Implementation of these indicators within routine monitoring of healthcare systems will highlight those conditions where hospitalisations could potentially be avoided through improved medication management.
可潜在预防的住院指标已在国际上被用作衡量卫生系统绩效的指标;然而,很少有指标评估围绕药物使用的适当护理流程,而遵循这些流程可能会预防住院。本研究的目的是开发并验证基于证据的与药物相关的可潜在预防住院的指标。
澳大利亚初级医疗保健。
医学专家、全科医生和药剂师。采用改良的兰德适宜性方法来制定与药物相关的可潜在预防住院的指标,其中包括文献综述、对支持证据基础强度的评估、由专家小组进行的初步表面效度和内容效度评估,随后由跨多个学科的专家临床小组通过在线调查对指标进行独立评估。
对可预防性的四个关键要素进行评分分析;与药物相关的问题必须是可识别的,不良后果是可预见的,原因和后果是可识别且可控的。
基于三级或更高级别的证据,针对所有主要疾病分组共制定了48个潜在指标,由78名专家临床医生进行独立评估(回复率为22.1%)。专家小组认为其中29个(60.4%)具有足够的效度。其中,21个(72.4%)基于一级证据。
本研究提供了一组经过表面效度和内容效度验证的与药物相关的可潜在预防住院的指标,将次优的护理流程和药物使用与随后的住院联系起来。需要进一步分析,以使用行政卫生数据库在基于人群的样本中确定操作效度。在医疗系统的常规监测中实施这些指标将突出那些通过改善药物管理有可能避免住院的情况。